Clinical WES
The Clinical WES test of CapitalBiotech is based on the BES4000 semiconductor sequencing platform, using target region capture and the NGS technology to detect nearly 4,000 genes that are clearly associated with genetic diseases, covering more than 4,200 diseases.
Individual WES
Covering 180,000+ exon regions of 20,000+ human genes, it comprehensively interprets all single-gene disorders with clear pathogenic genes in the OMIM database, and can search for new pathogenic genes with trio-WES method.
Metabolic Testing-Alcohol Metabolism Test
This test detects the genes related to alcohol metabolism in the human body and evaluates the alcohol metabolism ability of the subject.
WES+CNV-seq
The combination of individual WES and CNV-seq detects single-gene disorders and chromosomal diseases.
Metabolic Testing-Tobacco Damage
This test detects the metabolic process of chemical substances in tobacco and the genes related to the damage mechanism to the human body.
Metabolic Testing-Alcohol Damage
This test detects the metabolic process of chemical substances in alcohol and the genes related to the damage mechanism in the human body.
Metabolic Testing-Food Intolerance (50 Items)
It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 50 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.
Metabolic Testing-Food Intolerance (101 Items)
It covers 9 common food categories (including eggs and dairy, grains and nuts, meat, seafood, vegetables, fruits, yeast and beverages, seasonings, and traditional Chinese medicine) based on the microarray platform. It tests a total of 101 kinds of foods for IgG antibodies, and the best dietary plan for the subjects is formulated based on the results.
Intestinal Flora Testing
Intestinal flora testing uses a next-generation high-throughput sequencing platform and is based on 16S rDNA sequencing technology from the Human Microbiome Project.